Abstract

IntroductionBehcet's disease (BD) is a multi-systemic disorder with muco-cutaneous, ocular, arthritic, vascular or central nervous system involvement. The role of γδ T cells is implicated in BD. The activation status of γδ T cells and their cytokine secretion against phosphoantigens are evaluated in BD.MethodsNKG2A, NKG2C, NKG2D, CD16 and CCR7 molecules on γδ T cells were analyzed in 70 BD, 27 tuberculosis (TB) patients and 26 healthy controls (HC). Peripheral γδ T cells were expanded with a phosphoantigen (BrHPP) and IL-2, restimulated with BrHPP and a TLR3 ligand, and cytokine production was measured.Resultsγδ T cells were not increased in both BD and TB patients, but the proportions of TCRVδ2+ T cells were lower (58.9 and 50.7 vs. 71.7%, P = 0.04 and P = 0.005) compared to HC. Higher proportion of TCRVδ2+ T cells were CD16+ (26.2 and 33.9 vs. 16.6%, P = 0.02 and P = 0.001) and CCR7- (32.2 and 27.9 vs. 17.7%, P < 0.0001 and P = 0.014) in BD and TB patients compared to HC. NKG2C+ γδ+ T cells were relatively increased (0.5 and 0.6 vs. 0.3%, P = 0.008 and 0.018), whereas NKG2D positivity was decreased in patients with BD and TB (77.7 and 75.8 vs. 87.5%, P = 0.001 and 0.004). Expansion capacity of γδ T cells in BD and TB as well as production of IL-13, IFN-γ, granulocyte monocyte colony stimulating factor (GM-CSF), TNF-α, CCL4 and CCL5 in BD was lower compared to HC, when restimulated by TLR3 ligand and BrHPP.ConclusionThe changes on γδ T cells of BD as well as TB patients implicate that γδ T cells have already been exposed to regulatory effects, which changed their activity. Lower cytokine response of γδ T cells implicates down modulation of these cells in BD.

Highlights

  • Behcet’s disease (BD) is a multi-systemic disorder with muco-cutaneous, ocular, arthritic, vascular or central nervous system involvement

  • Phenotype of gδ T lymphocytes in peripheral blood The proportions of gδ+ T cells in peripheral blood mononuclear cells (PBMCs) were relatively low in BD patients and in both disease (TB) and healthy control (HC) groups (Table 2)

  • When compared among the pan gδ+ T cells, the dominance of TCRVδ2+ T cells was less prominent in BD and in the inactive BD (IA-BD) group compared to healthy controls (HC)

Read more

Summary

Introduction

Behcet’s disease (BD) is a multi-systemic disorder with muco-cutaneous, ocular, arthritic, vascular or central nervous system involvement. The activation status of gδ T cells and their cytokine secretion against phosphoantigens are evaluated in BD. Behcet’s disease (BD) is a systemic inflammatory disorder with a diverse spectrum of clinical manifestations including mucocutaneous, ocular, vascular, gastro-intestinal, musculoskeletal and central nervous system involvements. A complex genetic background leading to a pro-inflammatory, innate immune system derived activation perpetuated by adaptive immune responses against environmental or auto-antigens is considered as the pathogenic mechanism in BD [1,2,3]. In adults with negative purified protein derivative (PPD) response, TCRVg9Vδ2+ T cells reacting to isopentenyl pyrophosphate (IPP) secrete Th1 type cytokines (IFN-g, TNF-a) and MIP-1b (CCL4) [5]. The expression of CD16 regulated cytolytic activity and production of inflammatory cytokines of the gδ T cells

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.